Metabolic Therapy to Normalize Impaired Social Behaviour in a Pharmacological Animal Model of Schizophrenia

Conference Contribution ResearchOnline@JCU

Reid, Christopher A.R.;Roth, Cody;Finlay, Sabine;Robertson, Mark;Sarnyai, Zoltan

Abstract

[Extract] Schizophrenia is characterised by a mixture of psychotic (hallucinations, delusions) symptoms and social and cognitive impairments. While antipsychotic drugs provide relief for the psychotic symptoms in some patients, the social behavioral impairments do not respond well to traditional pharmacological approaches. Our main objective was to investigate the effects of novel metabolic treatment approaches (Sarnyai et al., 2020) that may normalize the “broken brain bioenergetics” on impaired social behavior in a pharmacological animal model of schizophrenia.

Journal

N/A

Publication Name

MHS 2022: 5th Annual Metabolic Health Summit

Volume

N/A

ISBN/ISSN

N/A

Edition

N/A

Issue

N/A

Pages Count

Location

Santa Barbara, CA, USA

Publisher

Metabolic Health Summit

Publisher Url

N/A

Publisher Location

Santa Barbara, CA, USA

Publish Date

N/A

Url

N/A

Date

N/A

EISSN

N/A

DOI

N/A